These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

424 related items for PubMed ID: 20516049

  • 1. Role of 2-month sputum smears in predicting culture conversion in pulmonary tuberculosis.
    Su WJ, Feng JY, Chiu YC, Huang SF, Lee YC.
    Eur Respir J; 2011 Feb; 37(2):376-83. PubMed ID: 20516049
    [Abstract] [Full Text] [Related]

  • 2. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R, Borgdorff MW, Sticht-Groh V, Rieder HL, Kawuma HJ, Bretzel G, Rüsch-Gerdes S.
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [Abstract] [Full Text] [Related]

  • 3. Viable Mycobacterium tuberculosis in sputum after pulmonary tuberculosis cure.
    Ambreen A, Jamil M, Rahman MAU, Mustafa T.
    BMC Infect Dis; 2019 Oct 30; 19(1):923. PubMed ID: 31666021
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis.
    Wang JY, Lee LN, Yu CJ, Chien YJ, Yang PC, Tami Group.
    Respirology; 2009 Sep 30; 14(7):1012-9. PubMed ID: 19659516
    [Abstract] [Full Text] [Related]

  • 6. Relative versus absolute noncontagiousness of respiratory tuberculosis on treatment.
    Long R, Bochar K, Chomyc S, Talbot J, Barrie J, Kunimoto D, Tilley P.
    Infect Control Hosp Epidemiol; 2003 Nov 30; 24(11):831-8. PubMed ID: 14649771
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [In 76% of patients with active tuberculosis treated with triple therapy (isoniazid-rifampicin-pyrazinamide) cultural conversion precedes microscopic conversion].
    Nowak D, Radenbach D, Magnussen H.
    Pneumologie; 1990 Feb 30; 44 Suppl 1():497-8. PubMed ID: 2114634
    [Abstract] [Full Text] [Related]

  • 10. Characteristics and outcome of tuberculosis patients whose sputum smears are positive at or after 5 months of treatment.
    Harries AD, Gausi F, Chimzizi R, Salaniponi FM.
    Int J Tuberc Lung Dis; 2004 Mar 30; 8(3):384-7. PubMed ID: 15139479
    [Abstract] [Full Text] [Related]

  • 11. Acid-fast bacilli in sputum smears of patients with pulmonary tuberculosis. Prevalence and significance of negative smears pretreatment and positive smears post-treatment.
    Kim TC, Blackman RS, Heatwole KM, Kim T, Rochester DF.
    Am Rev Respir Dis; 1984 Feb 30; 129(2):264-8. PubMed ID: 6421211
    [Abstract] [Full Text] [Related]

  • 12. Should we take a history of prior treatment, and check sputum status at 2-3 months when treating patients for tuberculosis?
    Wilkinson D, Bechan S, Connolly C, Standing E, Short GM.
    Int J Tuberc Lung Dis; 1998 Jan 30; 2(1):52-5. PubMed ID: 9562111
    [Abstract] [Full Text] [Related]

  • 13. Relationship between sputum smear grading and smear conversion rate and treatment outcome in the patients of pulmonary tuberculosis undergoing dots--a prospective cohort study.
    Tiwari S, Kumar A, Kapoor SK.
    Indian J Tuberc; 2012 Jul 30; 59(3):135-40. PubMed ID: 23362709
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Concentration-Dependent Antagonism and Culture Conversion in Pulmonary Tuberculosis.
    Rockwood N, Pasipanodya JG, Denti P, Sirgel F, Lesosky M, Gumbo T, Meintjes G, McIlleron H, Wilkinson RJ.
    Clin Infect Dis; 2017 May 15; 64(10):1350-1359. PubMed ID: 28205671
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Predictors of sputum culture conversion among patients treated for multidrug-resistant tuberculosis.
    Kurbatova EV, Gammino VM, Bayona J, Becerra MC, Danilovitz M, Falzon D, Gelmanova I, Keshavjee S, Leimane V, Mitnick CD, Quelapio MI, Riekstina V, Taylor A, Viiklepp P, Zignol M, Cegielski JP.
    Int J Tuberc Lung Dis; 2012 Oct 15; 16(10):1335-43. PubMed ID: 23107633
    [Abstract] [Full Text] [Related]

  • 18. Association of serum levels of iron, copper, and zinc, and inflammatory markers with bacteriological sputum conversion during tuberculosis treatment.
    Moraes ML, Ramalho DM, Delogo KN, Miranda PF, Mesquita ED, de Melo Guedes de Oliveira HM, Netto AR, Dos Anjos MJ, Kritski AL, de Oliveira MM.
    Biol Trace Elem Res; 2014 Aug 15; 160(2):176-84. PubMed ID: 24958018
    [Abstract] [Full Text] [Related]

  • 19. Adjuvant interferon gamma in patients with drug - resistant pulmonary tuberculosis: a pilot study.
    Suárez-Méndez R, García-García I, Fernández-Olivera N, Valdés-Quintana M, Milanés-Virelles MT, Carbonell D, Machado-Molina D, Valenzuela-Silva CM, López-Saura PA.
    BMC Infect Dis; 2004 Oct 22; 4():44. PubMed ID: 15500691
    [Abstract] [Full Text] [Related]

  • 20. Early bactericidal activity of ethambutol, pyrazinamide and the fixed combination of isoniazid, rifampicin and pyrazinamide (Rifater) in patients with pulmonary tuberculosis.
    Botha FJ, Sirgel FA, Parkin DP, van de Wal BW, Donald PR, Mitchison DA.
    S Afr Med J; 1996 Feb 22; 86(2):155-8. PubMed ID: 8619142
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.